ASTRAZENECA PLC - 22 Dec 2025 SCHEDULE 13D/A Report for Innate Pharma SA Ordinary Shares, EUR0.05 nominal value per share

Filing Manager
ASTRAZENECA PLC
Reporting Manager
AstraZeneca PLC
Security
Innate Pharma SA Ordinary Shares, EUR0.05 nominal value per share
Shares outstanding
94,283,145 shares
Disclosed Ownership
7,825,501 shares
Ownership
8.3%
Form type
SCHEDULE 13D/A
Filing time
06 Feb 2026, 09:48:38 UTC
Date of event
22 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
AstraZeneca PLC 8.3% 7,825,501 7,825,501 0 /s/ Matthew Bowden Matthew Bowden / Company Secretary 0000901832
MedImmune Limited 8.3% 7,825,501 7,825,501 0 /s/ Matthew Bowden Matthew Bowden / Director 0001790714